Trials / Withdrawn
WithdrawnNCT04150666
The Water Intake Trail and Primary Aldosteronism Postoperation(WIT-PAP)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Qifu Li · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To investigate whether increasing water intake has renal protective effect on PA patients after surgical treatment.
Detailed description
This is a single-center randomized controlled trial study to verify the effect of drinking water on renal function after PA surgery treatment and to follow up the clinical outcomes. We will take short-term follow-up on whether increasing water intake can improve eGFR decline in the early stage of PA patients after surgical treatment and further long-term follow-up to investigate whether increasing drinking water has long-term memory effect to slow down renal function deterioration and improve clinical outcomes. This study will be completed in 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Hydration | the same with arm descriptions |
Timeline
- Start date
- 2019-12-01
- Primary completion
- 2020-05-01
- Completion
- 2020-12-01
- First posted
- 2019-11-05
- Last updated
- 2020-07-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04150666. Inclusion in this directory is not an endorsement.